Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Boehringer Ingelheim
Merck
Baxter
McKesson

Last Updated: December 4, 2022

Eplerenone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drug Prices for eplerenone

See drug prices for eplerenone

Recent Clinical Trials for eplerenone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The George InstitutePhase 4
NHS National Waiting Times Centre BoardPhase 2
Victor Chang Cardiac Research InstitutePhase 4

See all eplerenone clinical trials

Pharmacology for eplerenone
Paragraph IV (Patent) Challenges for EPLERENONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
INSPRA Injection eplerenone 0.75 mg/mL, 100 mL vial 021437 1 2009-06-05
INSPRA Tablets eplerenone 25 mg and 50 mg 021437 2 2006-09-27

US Patents and Regulatory Information for eplerenone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prasco EPLERENONE eplerenone TABLET;ORAL 203896-001 Feb 2, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sandoz EPLERENONE eplerenone TABLET;ORAL 078510-001 Aug 1, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Kartha EPLERENONE eplerenone TABLET;ORAL 214663-002 Mar 23, 2022 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx EPLERENONE eplerenone TABLET;ORAL 078482-002 Jul 30, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Accord Hlthcare EPLERENONE eplerenone TABLET;ORAL 206922-002 Jul 13, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for eplerenone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn INSPRA eplerenone TABLET;ORAL 021437-002 Sep 27, 2002 See Plans and Pricing See Plans and Pricing
Upjohn INSPRA eplerenone TABLET;ORAL 021437-001 Sep 27, 2002 See Plans and Pricing See Plans and Pricing
Upjohn INSPRA eplerenone TABLET;ORAL 021437-001 Sep 27, 2002 See Plans and Pricing See Plans and Pricing
Upjohn INSPRA eplerenone TABLET;ORAL 021437-002 Sep 27, 2002 See Plans and Pricing See Plans and Pricing
Upjohn INSPRA eplerenone TABLET;ORAL 021437-001 Sep 27, 2002 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Medtronic
Baxter
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.